Clinical trial
Clotild® Smart Guidewire System Evaluation in Endovascular Thrombectomy Procedure
NCT04993079 is registered in ClinicalTrials.gov with Sensome as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clotild® Smart Guidewire System Evaluation in Endovascular Thrombectomy Procedure
- Lead sponsor
- Sensome
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 26, 2021
- Completion date
- April 16, 2024
- Enrollment
- 45 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.